GeneDx Holdings (WGS) Operating Income (2020 - 2025)
Historic Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$3.3 million.
- GeneDx Holdings' Operating Income rose 5821.34% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 11728.0%. This contributed to the annual value of -$23.2 million for FY2024, which is 8714.64% up from last year.
- According to the latest figures from Q3 2025, GeneDx Holdings' Operating Income is -$3.3 million, which was up 5821.34% from $9.0 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Operating Income registered a high of $9.0 million during Q2 2025, and its lowest value of -$324.9 million during Q4 2022.
- In the last 5 years, GeneDx Holdings' Operating Income had a median value of -$45.4 million in 2021 and averaged -$69.3 million.
- In the last 5 years, GeneDx Holdings' Operating Income plummeted by 25787.93% in 2022 and then soared by 18469.61% in 2025.
- GeneDx Holdings' Operating Income (Quarter) stood at -$115.8 million in 2021, then tumbled by 180.6% to -$324.9 million in 2022, then skyrocketed by 92.11% to -$25.6 million in 2023, then surged by 134.34% to $8.8 million in 2024, then plummeted by 136.92% to -$3.3 million in 2025.
- Its Operating Income stands at -$3.3 million for Q3 2025, versus $9.0 million for Q2 2025 and -$4.6 million for Q1 2025.